Cargando…
Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling
BACKGROUND: Coronary heart disease (CHD) and stroke were key outcomes in the Women's Health Initiative (WHI) randomized trials of postmenopausal estrogen and estrogen plus progestin therapy. We recently reported a large number of changes in blood protein concentrations in the first year followi...
Autores principales: | Prentice, Ross L, Paczesny, Sophie, Aragaki, Aaron, Amon, Lynn M, Chen, Lin, Pitteri, Sharon J, McIntosh, Martin, Wang, Pei, Buson Busald, Tina, Hsia, Judith, Jackson, Rebecca D, Rossouw, Jacques E, Manson, JoAnn E, Johnson, Karen, Eaton, Charles, Hanash, Samir M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923740/ https://www.ncbi.nlm.nih.gov/pubmed/20667078 http://dx.doi.org/10.1186/gm169 |
Ejemplares similares
-
Postmenopausal estrogen and progestin effects on the serum proteome
por: Pitteri, Sharon J, et al.
Publicado: (2009) -
Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings
por: Katayama, Hiroyuki, et al.
Publicado: (2009) -
Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases
por: Prentice, Ross L, et al.
Publicado: (2013) -
Plasma Proteome Profiles Associated with Inflammation, Angiogenesis, and Cancer
por: Kelly-Spratt, Karen S., et al.
Publicado: (2011) -
Low-Fat Dietary Pattern among Postmenopausal Women Influences Long-Term Cancer, Cardiovascular Disease, and Diabetes Outcomes
por: Prentice, Ross L, et al.
Publicado: (2019)